JPMorgan Recommends Eli Lilly, AbbVie, Danaher as Top Healthcare Stocks
Published on · Source: marketwatch.com
AI Summary
Summarized by AI from the source belowJPMorgan has identified Eli Lilly, AbbVie, and Danaher Corporation as top picks within the healthcare sector. Investors are currently overlooking these stocks, which may present buying opportunities. The recommendation suggests potential growth in these companies as market dynamics shift. This could lead to increased interest and investment in these healthcare stocks, impacting their market performance positively for investors. Eli Lilly (LLY), AbbVie (ABBV), and Danaher (DHR) are highlighted for consideration.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About AbbVie Inc. (ABBV)
AbbVie is a research-based pharmaceutical company with a portfolio spanning immunology, oncology, and neuroscience.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier ABBV news
- AbbVie (ABBV) Stock May Move 4.2% on July 31 Earnings Report
- AbbVie (ABBV) Reports 2.8% Yield; Baxter (BAX) Cuts Dividend
- Jefferies Recommends AbbVie (ABBV) as Quality Stock Amid AI Concerns
- AbbVie (ABBV) Hits New 52-Week High; Stock Up 40% Yearly
- AbbVie (ABBV) Acquires Apogee for $10.9 Billion Eczema Drug
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
